Management of Acute Respiratory Distress Syndrome (ARDS): A Review of Current Ventilatory and Pharmacological Strategies
DOI:
https://doi.org/10.12775/JEHS.2025.81.59770Keywords
Acute Respiratory Distress Syndrome, lung-protective ventilation, prone positioning, pharmacological interventions, ARDS phenotypesAbstract
Introduction and Purpose. Acute Respiratory Distress Syndrome (ARDS) is a severe inflammatory lung condition associated with high mortality. Despite advances in intensive care, optimal management remains a challenge. This review synthesizes current ventilatory and pharmacological strategies, emphasizing precision medicine to improve outcomes.
Material and Methods. A comprehensive literature search was conducted using PubMed and Google Scholar, focusing on ARDS management studies published since 2015. Keywords included "ARDS," "mechanical ventilation," "prone positioning," "pharmacological therapy," and "precision medicine."
Brief Description of the State of Knowledge. Lung-protective ventilation, utilizing low tidal volumes and prone positioning, significantly reduces mortality in ARDS. Positive end-expiratory pressure (PEEP) optimization and extracorporeal membrane oxygenation (ECMO) serve as adjunct strategies in severe cases. Pharmacological approaches, including early corticosteroid administration and neuromuscular blocking agents, show selective benefits, particularly in hyperinflammatory ARDS phenotypes. Novel therapies, such as mesenchymal stem cells, IL-1β inhibitors, and machine learning-assisted ventilation strategies, represent promising future directions.
Conclusions. ARDS management is evolving toward a personalized, phenotype-driven approach integrating ventilatory and pharmacological strategies. Despite significant advances, challenges remain in optimizing corticosteroid use, PEEP titration, and ECMO application. Future research should focus on biomarker-driven therapies and artificial intelligence-assisted ventilation to enhance patient outcomes and reduce mortality.
References
1. Rezoagli E, Fumagalli R, Bellani G. Definition and epidemiology of acute respiratory distress syndrome. Annals of Translational Medicine. 2017;5(14):282-282. doi:https://doi.org/10.21037/atm.2017.06.62
2. Estenssoro E, Iván González, Plotnikow GA. Post-pandemic acute respiratory distress syndrome: A New Global Definition with extension to lower-resource regions. Medicina Intensiva (English Edition). 2024;48(5):272-281. doi:https://doi.org/10.1016/j.medine.2024.01.011
3. Matthay MA, Zemans RL, Zimmerman GA, et al. Acute Respiratory Distress Syndrome. Nature Reviews Disease Primers. 2019;5(1). doi:https://doi.org/10.1038/s41572-019-0069-0
4. Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. The Lancet. 2022;400(10358):1145-1156. doi:https://doi.org/10.1016/s0140-6736(22)01485-4
5. Swenson KE, Swenson ER. Pathophysiology of ARDS and COVID-19 Lung Injury. Critical Care Clinics. 2021;37(4):749-776. doi:https://doi.org/10.1016/j.ccc.2021.05.003
6. Lu S, Huang X, Liu R, et al. Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences. Frontiers in Medicine. 2022;9:829771. doi:https://doi.org/10.3389/fmed.2022.829771
7. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. The Lancet Respiratory Medicine. 2020;0(0). doi:https://doi.org/10.1016/S2213-2600(20)30370-2
8. Pfeilsticker FJ do A, Serpa Neto A. “Lung-protective” ventilation in acute respiratory distress syndrome: still a challenge?. Journal of Thoracic Disease. 2017;9(8):2238-2241. doi:https://doi.org/10.21037/jtd.2017.06.145
9. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. The New England journal of medicine. 2000;342(18):1301-1308. doi:https://doi.org/10.1056/NEJM200005043421801
10. The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome. New England Journal of Medicine. 2004;351(4):327-336. doi:https://doi.org/10.1056/nejmoa032193
11. Guérin C, Albert RK, Beitler J, et al. Prone Position in ARDS patients: Why, when, How and for Whom. Intensive Care Medicine. 2020;46(12):2385-2396. doi:https://doi.org/10.1007/s00134-020-06306-w
12. Kallet RH. A Comprehensive Review of Prone Position in ARDS. Respiratory Care. 2015;60(11):1660-1687. doi:https://doi.org/10.4187/respcare.04271
13. Hoshino T, Yoshida T. Future directions of lung-protective ventilation strategies in acute respiratory distress syndrome. Acute Medicine & Surgery. 2024;11(1):e918. doi:https://doi.org/10.1002/ams2.918
14. Spinelli E, Giani M, Slobod D, et al. Physiologic Effects of ECMO in Patients with Severe Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 2024;210(5):629-638. doi:https://doi.org/10.1164/rccm.202309-1688oc
15. Gómez-Hernández MT, Martínez EJ, Fuentes MG, et al. Extracorporeal membrane oxygenation (ECMO) as bridge therapy to surgery in a patient with acute respiratory distress syndrome (ARDS) due to rupture of a pulmonary hydatid cyst. Archivos de Bronconeumología (English Edition). 2021;57(7):503-504. doi:https://doi.org/10.1016/j.arbr.2021.05.005
16. Vincent JL. High-Frequency Oscillation in Acute Respiratory Distress Syndrome. The End of the Story? American Journal of Respiratory and Critical Care Medicine. 2017;196(6):670-671. doi:https://doi.org/10.1164/rccm.201703-0475ed
17. Miller AG, Tan HL, Smith BJ, Rotta AT, Lee JH. The Physiological Basis of High-Frequency Oscillatory Ventilation and Current Evidence in Adults and Children: A Narrative Review. Frontiers in Physiology. 2022;13. doi:https://doi.org/10.3389/fphys.2022.813478
18. Bhattacharjee S, Soni KD, Maitra S. Recruitment maneuver does not provide any mortality benefit over lung protective strategy ventilation in adult patients with acute respiratory distress syndrome: a meta-analysis and systematic review of the randomized controlled trials. Journal of Intensive Care. 2018;6(1). doi:https://doi.org/10.1186/s40560-018-0305-9
19. Hess DR. Recruitment Maneuvers and PEEP Titration. Respiratory Care. 2015;60(11):1688-1704. doi:https://doi.org/10.4187/respcare.04409
20. Qadir N, Chang SY. Pharmacologic Treatments for Acute Respiratory Distress Syndrome. Critical Care Clinics. 2021;37(4):877-893. doi:https://doi.org/10.1016/j.ccc.2021.05.009
21. Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. The Lancet Respiratory Medicine. 2020;8(3):267-276. doi:https://doi.org/10.1016/s2213-2600(19)30417-5
22. Boyle AJ, Sweeney RM, McAuley DF. Pharmacological treatments in ARDS; a state-of-the-art update. BMC Medicine. 2013;11:166. doi:https://doi.org/10.1186/1741-7015-11-166
23. Ragel EJ, Harris LK, Campbell RA. Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses—a systematic review. BMJ Open Respiratory Research. 2023;10(1):e001525-e001525. doi:https://doi.org/10.1136/bmjresp-2022-001525
24. Battaglini D, Iavarone IG, Patricia. An update on the pharmacological management of acute respiratory distress syndrome. Expert Opinion on Pharmacotherapy. 2024;25(9):1229-1247. doi:https://doi.org/10.1080/14656566.2024.2374461
25. Wu L, Lei Q, Gao Z, Zhang W. Research Progress on Phenotypic Classification of Acute Respiratory Distress Syndrome: A Narrative Review. International Journal of General Medicine. 2022;Volume 15:8767-8774. doi:https://doi.org/10.2147/ijgm.s391969
26. Alipanah N, Calfee CS. Phenotyping in acute respiratory distress syndrome: state of the art and clinical implications. Current Opinion in Critical Care. 2021;28(1):1-8. doi:https://doi.org/10.1097/mcc.0000000000000903
27. Qadir N, Sahetya SK, Munshi L, et al. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2024;209(1):24-36. doi:https://doi.org/10.1164/rccm.202311-2011st
28. Krynytska I, Marushchak M, Birchenko I, Dovgalyuk A, Tokarskyy O. COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review). Iranian Journal of Microbiology. 2021;13(6). doi:https://doi.org/10.18502/ijm.v13i6.8072
29. Kuljit K, Knight GE, Soo A, et al. Designing a Behaviour Change Wheel guided implementation strategy for a hypoxaemic respiratory failure and ARDS care pathway that targets barriers. BMJ open quality. 2023;12(4):e002461-e002461. doi:https://doi.org/10.1136/bmjoq-2023-002461
30. Vignon P, Evrard B, Asfar P, et al. Fluid administration and monitoring in ARDS: which management? Intensive Care Medicine. 2020;46(12):2252-2264. doi:https://doi.org/10.1007/s00134-020-06310-0
31. Riviello ED, Pisani L, Schultz MJ. What’s new in ARDS: ARDS also exists in resource-constrained settings. Intensive Care Medicine. 2016;42(5):794-796. doi:https://doi.org/10.1007/s00134-016-4308-5
32. Matthay MA, Arabi Y, Arroliga AC, et al. A New Global Definition of Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 2023;209(1). doi:https://doi.org/10.1164/rccm.202303-0558WS
33. Battaglini D, Guérin CE, Rocco PRM. Editorial: Personalized therapy in ARDS, volume II. Frontiers in Medicine. 2024;11. doi:https://doi.org/10.3389/fmed.2024.1533593
34. Griffiths MJD, McAuley DF, Perkins GD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respiratory Research. 2019;6(1):e000420. doi:https://doi.org/10.1136/bmjresp-2019-000420
35. Sinha P, Neyton L, Sarma A, et al. Molecular Phenotypes of ARDS in the ROSE Trial have Differential Outcomes and Gene Expression Patterns That Differ at Baseline and Longitudinally Over Time. American journal of respiratory and critical care medicine. Published online February 12, 2024. doi:https://doi.org/10.1164/rccm.202308-1490oc
36. Ma W, Tang S, Yao P, et al. Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. Signal Transduction and Targeted Therapy. 2025;10(1). doi:https://doi.org/10.1038/s41392-025-02127-9
37. Beitler JR, Goligher EC, Schmidt M, et al. Personalized medicine for ARDS: the 2035 research agenda. Intensive Care Medicine. 2016;42(5):756-767. doi:https://doi.org/10.1007/s00134-016-4331-6
38. Nasa P, Bos LD, Estenssoro E, et al. Consensus statements on the utility of defining ARDS and the utility of past and current definitions of ARDS—protocol for a Delphi study. BMJ Open. 2024;14(4):e082986-e082986. doi:https://doi.org/10.1136/bmjopen-2023-082986
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jan Pielacinski, Szymon Pucyło, Mateusz Nieczyporuk , Martyna Skweres, Gabriela Piotrowska, Katarzyna Ceglarz, Aleksander Rudnik, Kinga Sikora
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 275
Number of citations: 0
